GDPD5 and Alzheimer disease: Loss of GDE2 recapitulates cellular and behavioral abnormalities observed in AD and ALS–FTD (Nakamura et al., 2021; Westerhaus et al., 2022; Daudelin et al., 2024; Zhang et al., 2024).